Drug trial halted for bowel disease treatment
NCT ID NCT01671956
Summary
This study tested whether an experimental drug called bertilimumab could help control the symptoms of moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. It involved 32 adults and compared the drug's effects against a placebo over 56 days. The trial was terminated early, and its full results for safety and effectiveness are not publicly available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS, ACTIVE MODERATE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Afula, Israel
-
Research Site
Holon, 58100, Israel
-
Research Site
Jerusalem, 91031, Israel
-
Research Site
Jerusalem, 91120, Israel
-
Research Site
Kfar Saba, 44299, Israel
-
Research Site
Tel Aviv, 64239, Israel
Conditions
Explore the condition pages connected to this study.